[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100514700":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":43,"collaborators":47,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Asan Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"XIENCE Skypoint™ stent",null,"Patients receiving Xience-Skypoint™ stents",[13],"Device: XIENCE Skypoint™ stent",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":10},"DEVICE","Percutaneous coronary intervention with Xience-Skypoint™ stent",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Jung-hee Ham, Project manager","CONTACT","82230104728","cvcrc5@amc.seoul.kr",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":10,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Asan Medical Hospital","RECRUITING","Seoul","South Korea",{"type":32,"coordinates":33},"Point",[34,35],126.9784,37.566,{"lat":35,"lon":34},[38,41],{"name":39,"role":22,"phone":10,"phoneExt":10,"email":40},"Seung-jung Park, MD","sjpark@amc.seoul.kr",{"name":39,"role":42,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Seung-Jung Park","Professor, Department of Cardiology, University of Ulsan College of Medicine",[48],{"name":49,"class":6},"CardioVascular Research Foundation, Korea","100514700","evaluation-of-effectiveness-and-safety-of-xience-skypoint-stents-in-routine-clinical-practice-100514700",false,"NCT05981911","Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice","a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease","IRIS Skypoint","Inclusion Criteria:\n\n1. Patients ≥ 19 years old\n2. Patients receiving Xience-Skypoint™ stents.\n3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board\u002FEthics Committee of the respective clinical site.\n\nExclusion Criteria:\n\n1. Patients with a mixture of other DESs\n2. Terminal illness with life expectancy \\\u003C1 year\n3. Patients with cardiogenic shock","ALL","19 Years",{"count":61,"type":62},2000,"ESTIMATED","OBSERVATIONAL","The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.",[66],"Coronary Artery Disease",[68,69],"drug eluting stent","Percutaneous Coronary Intervention","2025-12-28",{"date":72,"type":73},"2026-01-02","ACTUAL",{"date":75,"type":73},"2023-12-14",{"date":77,"type":62},"2026-12",{"name":45,"class":6},1]